4//SEC Filing
GLAXOSMITHKLINE PLC 4
Accession 0001387131-21-006822
$GSKCIK 0001806952other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:14 PM ET
Size
7.8 KB
Accession
0001387131-21-006822
Insider Transaction Report
Form 4
GLAXOSMITHKLINE PLC
10% Owner
Transactions
- Conversion
Common Stock
2021-06-21+30,253,189→ 30,253,189 total(indirect: See Footnote) - Conversion
Series AA Preferred Stock
2021-06-21−30,253,189→ 0 total(indirect: See Footnote)→ Common Stock (30,253,189 underlying)
Footnotes (2)
- [F1]The Series AA Preferred Stock automatically converted into common stock on a 1-for-1 basis into the number of shares of common stock shown in Column 7 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]The shares reported herein are held of record by Glaxo Group Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001131399
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:14 PM ET
- Size
- 7.8 KB